Biblio

Found 27 results
Filters: Author is Allen, Naomi E  [Clear All Filters]
2012
Grote VA, Nieters A, Kaaks R, Tjønneland A, Roswall N, Overvad K, Nielsen M SR, Clavel-Chapelon F, Boutron-Ruault M C, Racine A et al..  2012.  The associations of advanced glycation end products and its soluble receptor with pancreatic cancer risk: a case-control study within the prospective EPIC Cohort.. Cancer Epidemiol Biomarkers Prev. 21(4):619-28.
Duell EJ, Sala N, Travier N, Muñoz X, Boutron-Ruault M C, Clavel-Chapelon F, Barricarte A, Arriola L, Navarro C, Sánchez-Cantalejo E et al..  2012.  Genetic variation in alcohol dehydrogenase (ADH1A, ADH1B, ADH1C, ADH7) and aldehyde dehydrogenase (ALDH2), alcohol consumption and gastric cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort.. Carcinogenesis. 33(2):361-7.
Wu X, Scelo G, Purdue MP, Rothman N, Johansson M, Ye Y, Wang Z, Zelenika D, Moore LE, Wood CG et al..  2012.  A genome-wide association study identifies a novel susceptibility locus for renal cell carcinoma on 12p11.23.. Hum Mol Genet. 21(2):456-62.
Agudo A, Bonet C, Travier N, González CA, Vineis P, Bueno-de-Mesquita BH, Trichopoulos D, Boffetta P, Clavel-Chapelon F, Boutron-Ruault M-C et al..  2012.  Impact of cigarette smoking on cancer risk in the European prospective investigation into cancer and nutrition study.. J Clin Oncol. 30(36):4550-7.
Aleksandrova K, Boeing H, Jenab M, Bueno-de-Mesquita BH, Jansen E, van Duijnhoven FJB, Rinaldi S, Fedirko V, Romieu I, Riboli E et al..  2012.  Leptin and soluble leptin receptor in risk of colorectal cancer in the European Prospective Investigation into Cancer and Nutrition cohort.. Cancer Res. 72(20):5328-37.
Leenders M, Chuang S-C, Dahm CC, Overvad K, Ueland P M, Midttun O, Vollset S E, Tjønneland A, Halkjaer J, Jenab M et al..  2012.  Plasma cotinine levels and pancreatic cancer in the EPIC cohort study.. Int J Cancer. 131(4):997-1002.
Travis RC, Allen NE, Appleby PN, Price A, Kaaks R, Chang-Claude J, Boeing H, Aleksandrova K, Tjønneland A, Johnsen N F et al..  2012.  Prediagnostic concentrations of plasma genistein and prostate cancer risk in 1,605 men with prostate cancer and 1,697 matched control participants in EPIC.. Cancer Causes Control. 23(7):1163-71.
Sala N, Muñoz X, Travier N, Agudo A, Duell EJ, Moreno V, Overvad K, Tjonneland A, Boutron-Ruault M C, Clavel-Chapelon F et al..  2012.  Prostate stem-cell antigen gene is associated with diffuse and intestinal gastric cancer in Caucasians: results from the EPIC-EURGAST study.. Int J Cancer. 130(10):2417-27.
Hoggart C, Brennan P, Tjonneland A, Vogel U, Overvad K, Østergaard J N, Kaaks R, Canzian F, Boeing H, Steffen A et al..  2012.  A risk model for lung cancer incidence.. Cancer Prev Res (Phila). 5(6):834-46.
Aleksandrova K, Boeing H, Jenab M, Bueno-de-Mesquita BH, Jansen E, van Duijnhoven FJB, Fedirko V, Rinaldi S, Romieu I, Riboli E et al..  2012.  Total and high-molecular weight adiponectin and risk of colorectal cancer: the European Prospective Investigation into Cancer and Nutrition Study.. Carcinogenesis. 33(6):1211-8.
2011
Balassiano K, Lima S, Jenab M, Overvad K, Tjonneland A, Boutron-Ruault M C, Clavel-Chapelon F, Canzian F, Kaaks R, Boeing H et al..  2011.  Aberrant DNA methylation of cancer-associated genes in gastric cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST).. Cancer Lett. 311(1):85-95.
Schütze M, Boeing H, Pischon T, Rehm J, Kehoe T, Gmel G, Olsen A, Tjønneland AM, Dahm CC, Overvad K et al..  2011.  Alcohol attributable burden of incidence of cancer in eight European countries based on results from prospective cohort study.. BMJ. 342:d1584.
Michaud DS, Bové G, Gallo V, Schlehofer B, Tjønneland A, Olsen A, Overvad K, Dahm CC, Teucher B, Boeing H et al..  2011.  Anthropometric measures, physical activity, and risk of glioma and meningioma in a large prospective cohort study.. Cancer Prev Res (Phila). 4(9):1385-92.
Menvielle G, Kunst AE, van Gils CH, Peeters PH, Boshuizen H, Overvad K, Olsen A, Tjonneland A, Hermann S, Kaaks R et al..  2011.  The contribution of risk factors to the higher incidence of invasive and in situ breast cancers in women with higher levels of education in the European prospective investigation into cancer and nutrition.. Am J Epidemiol. 173(1):26-37.
Rinaldi S, Plummer M, Biessy C, Castellsagué X, Overvad K, Krüger Kjær S, Tjønneland A, Clavel-Chapelon F, Chabbert-Buffet N, Mesrine S et al..  2011.  Endogenous sex steroids and risk of cervical carcinoma: results from the EPIC study.. Cancer Epidemiol Biomarkers Prev. 20(12):2532-40.
Timofeeva MN, McKay JD, Smith G D, Johansson M, Byrnes GB, Chabrier A, Relton C, Ueland P M, Vollset S E, Midttun Ø et al..  2011.  Genetic polymorphisms in 15q25 and 19q13 loci, cotinine levels, and risk of lung cancer in EPIC.. Cancer Epidemiol Biomarkers Prev. 20(10):2250-61.
Campa D, Hüsing A, Dostal L, Stein A, Drogan D, Boeing H, Tjønneland A, Roswall N, Østergaard J N, Overvad K et al..  2011.  Genetic variability of the forkhead box O3 and prostate cancer risk in the European Prospective Investigation on Cancer.. Oncol Rep. 26(4):979-86.
Schumacher FR, Berndt SI, Siddiq A, Jacobs KB, Wang Z, Lindstrom S, Stevens VL, Chen C, Mondul AM, Travis RC et al..  2011.  Genome-wide association study identifies new prostate cancer susceptibility loci.. Hum Mol Genet. 20(19):3867-75.
Purdue MP, Johansson M, Zelenika D, Toro JR, Scelo G, Moore LE, Prokhortchouk E, Wu X, Kiemeney LA, Gaborieau V et al..  2011.  Genome-wide association study of renal cell carcinoma identifies two susceptibility loci on 2p21 and 11q13.3.. Nat Genet. 43(1):60-5.
Aleksandrova K, Boeing H, Jenab M, Bas Bueno-de-Mesquita H, Jansen E, van Duijnhoven FJB, Fedirko V, Rinaldi S, Romieu I, Riboli E et al..  2011.  Metabolic syndrome and risks of colon and rectal cancer: the European prospective investigation into cancer and nutrition study.. Cancer Prev Res (Phila). 4(11):1873-83.
van Veldhoven CM, Khan AE, Teucher B, Rohrmann S, Raaschou-Nielsen O, Tjønneland A, Overvad K, Vigl M, Boeing H, Benetou V et al..  2011.  Physical activity and lymphoid neoplasms in the European Prospective Investigation into Cancer and nutrition (EPIC).. Eur J Cancer. 47(5):748-60.
Chajès V, Jenab M, Romieu I, Ferrari P, Dahm CC, Overvad K, Egeberg R, Tjønneland A, Clavel-Chapelon F, Boutron-Ruault M-C et al..  2011.  Plasma phospholipid fatty acid concentrations and risk of gastric adenocarcinomas in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST).. Am J Clin Nutr. 94(5):1304-13.
Jakszyn P, González CA, Luján-Barroso L, Ros MM, Bueno-de-Mesquita BH, Roswall N, Tjønneland AM, Büchner FL, Egevad L, Overvad K et al..  2011.  Red meat, dietary nitrosamines, and heme iron and risk of bladder cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC).. Cancer Epidemiol Biomarkers Prev. 20(3):555-9.
Baltar V T, Xun WW, Chuang S-C, Relton C, Ueland P M, Vollset S E, Midttun Ø, Johansson M, Slimani N, Jenab M et al..  2011.  Smoking, secondhand smoke, and cotinine levels in a subset of EPIC cohort.. Cancer Epidemiol Biomarkers Prev. 20(5):869-75.